1. State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer
Oncol Res Treat 2016;39: DOI: /
Fig. 1. Kaplan-Meier curves of progression-free survival (PFS) stratified by the number of risk factors being present in 3 patient groups (low-risk = 0-1 risk factors; mid-risk = 2-3 risk factors; high-risk = 4-5 risk factors) (from [31] with permission).
© 2016 S. Karger AG, Basel

2. State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer
Oncol Res Treat 2016;39: DOI: /
Fig. 2. Kaplan-Meier curves of overall and progression-free survival in women with cervical cancer recurrence and chemotherapy with carboplatin/paclitaxel and cisplatin/paclitaxel (from [32] with permission).
© 2016 S. Karger AG, Basel

3. State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer
Oncol Res Treat 2016;39: DOI: /
Fig. 3. Kaplan-Meier curves of overall and progression-free survival in women with cervical cancer recurrence and chemotherapy with and without bevacizumab (from [34] with permission).
© 2016 S. Karger AG, Basel